Recursion Pharmaceuticals Stock Performance
as on October 10, 2026 at 2:15 pm IST
Day's Low
Day's High
$3.89$4.43
10.78%
Downside
1.61%
Upside
52 Week's Low
52 Week's High
$2.77$7.1836.47%
Downside
64.68%
Upside
Recursion Pharmaceuticals share price movements today
- Previous Close
- $3.95
- Open
- $3.99
- Volume
- 38.8M
- Market Cap
- $2.1B
- Day's Low - High
- $3.89 - $4.43
- 52 Week Low - High
- $2.77 - $7.18
Recursion Pharmaceuticals Historical Returns
- 1 Month Return
- + 37.97 %
- 3 Month Return
- + 22.47 %
- 1 Year Return
- -18.05 %
- 3 Year Return
- -38.33 %
- 5 Year Return
- -76.66 %
Recursion Pharmaceuticals Stock Fundamentals & Key Indicators
Check Recursion Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
-1.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.8
Industry PE ratio
-11.19
PEG Ratio
-0.07
EBITDA
-444.4M
Revenue (TTM)
54.9M
Profit Margin
-46.66%
Return On Equity TTM
-50.41%
Recursion Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $2.1B | -76.66% | -3.80 | -46.66% | 0.00% | |
| Neutral | $78.6B | -26.21% | -24.69 | -12.57% | 0.00% | |
| StrongBuy | $127.6B | 185.06% | 29.06 | 86.04% | 0.00% | |
| Buy | $76.4B | 35.73% | 17.66 | 84.86% | 0.50% |
Stock Returns calculator for Recursion Pharmaceuticals Stock including INR - Dollar returns
The Recursion Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Recursion Pharmaceuticals investment value today
Current value as on today
₹89,208
Returns
Returns from Recursion Pharmaceuticals Stock
Dollar Impact
₹7,253 (+7.25%)
Analyst Recommendation on Recursion Pharmaceuticals Stock
Based on 3 analysts
33.33%
Buy
66.67%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals. Average target price of $7.22
Recursion Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Recursion Pharmaceuticals.
What analysts predicted
39.61%UPSIDE
Target Price
$7.22
Current Price
$4.36
Analyzed by
3 Analysts
High
$8
Target
$7.22
Low
$5.3
Recursion Pharmaceuticals target price $7.22, a slight upside of 39.61% compared to current price of $4.36. According to 3 analysts rating.
Indian Investors' Interest in Recursion Pharmaceuticals Stock
Investment in Recursion Pharmaceuticals Shares on INDmoney has grown by 29.19% in the last 30 days, indicating increased investment activity.
Time period: to
Change:29.19% versus previous 30 day period
Search interest for Recursion Pharmaceuticals Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:49% versus previous 30 day period
Recursion Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals News & Key Events
Today's Timeline - 21 September
Mon, 06:50 PM
-Recursion and Tempus extend data partnership and license Recursion's RNA sequencing model, amending financial terms.
Insights on Recursion Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 6.47M → 7.67M (in $), with an average increase of 15.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, RXRX stock has moved up by 5.8%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 756.6%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 115.5% return, outperforming this stock by 153.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -108.12M → -131.00M (in $), with an average decrease of 10.1% per quarter
About Recursion Pharmaceuticals
| Organisation | Recursion Pharmaceuticals |
| Headquarters | 41 South Rio Grande Street, Salt Lake City, UT, 84101, US |
| Industry | Biotechnology |
| CEO | Najat Khan |
Key Management of Recursion Pharmaceuticals
Name | Title |
|---|---|
Dr. Najat Khan Ph.D. | CEO, President & Director |
Mr. Nathan Hatfield J.D., M.B.A. | Chief Legal Officer & Corporate Secretary |
Ms. Erica Fox | Chief People and Impact Officer |
Mr. Sid Jain | Senior Vice President of Clinical Development & Data Science |
Dr. Vicki L. Goodman M.D. | Chief Medical Officer |
Mr. Ben R. Taylor | CFO & President of Recursion UK |
Mr. Benjamin Mabey M.S. | Chief Technology Officer |
Dr. David Hallett Ph.D. | Chief Scientific Officer |
Mr. Ryan Kelly | Chief Communications Officer |
Mr. Matthew Kinn M.B.A. | Chief Business Officer |
FAQs
What is Recursion Pharmaceuticals share price today?
Recursion Pharmaceuticals share price today is $4.36 as on at the close of the market. Recursion Pharmaceuticals share today touched a day high of $4.43 and a low of $3.89.
What is the 52 week high and 52 week low for Recursion Pharmaceuticals share?
Recursion Pharmaceuticals share touched a 52 week high of $7.18 on and a 52 week low of $2.77 on . Recursion Pharmaceuticals stock price today i.e. is closed at $4.36,which is 39.28% down from its 52 week high and 57.40% up from its 52 week low.
What is Recursion Pharmaceuticals's market capitalisation today?
Recursion Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Recursion Pharmaceuticals Stock (RXRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Recursion Pharmaceuticals on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Recursion Pharmaceuticals Stock (RXRX) from India?
Indian investors can start investing in Recursion Pharmaceuticals (RXRX) shares with as little as ₹96.730003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.30 in Recursion Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Recursion Pharmaceuticals share’s latest price of $4.36 as on October 10, 2026 at 8:45 am IST, you will get 2.2936 shares of Recursion Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Recursion Pharmaceuticals has given to Indian investors in the last 5 years?
Recursion Pharmaceuticals stock has given -76.66% share price returns and 27.85% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?